MustGrow Biologics Corp. (TSXV: MGRO)
Canada
· Delayed Price · Currency is CAD
1.810
-0.030 (-1.63%)
Nov 22, 2024, 3:59 PM EST
MustGrow Biologics Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 4.67 | 6.82 | 7.02 | 9.62 | 3.31 | 4.03 | Upgrade
|
Cash & Short-Term Investments | 4.67 | 6.82 | 7.02 | 9.62 | 3.31 | 4.03 | Upgrade
|
Cash Growth | -6.65% | -2.84% | -27.07% | 190.39% | -17.77% | 694.12% | Upgrade
|
Other Receivables | 0.18 | 0.09 | 0.09 | 0.06 | 0.03 | 0.06 | Upgrade
|
Receivables | 0.18 | 0.09 | 0.09 | 0.06 | 0.03 | 0.06 | Upgrade
|
Prepaid Expenses | 0.01 | 0.03 | 0.03 | 0.02 | 0.03 | 0.01 | Upgrade
|
Total Current Assets | 4.89 | 6.94 | 7.13 | 9.7 | 3.37 | 4.09 | Upgrade
|
Total Assets | 4.89 | 6.94 | 7.13 | 9.7 | 3.37 | 4.09 | Upgrade
|
Accounts Payable | 0.32 | 0.28 | 0.19 | 0.23 | 0.11 | 0.09 | Upgrade
|
Accrued Expenses | 0.04 | 0.04 | 0.03 | 0.27 | 0.04 | 0.01 | Upgrade
|
Short-Term Debt | - | - | - | - | 0.21 | 0.21 | Upgrade
|
Current Portion of Long-Term Debt | 0.38 | 0.62 | 0.4 | 0.37 | - | 0.37 | Upgrade
|
Current Unearned Revenue | 0.27 | 0.27 | 0.91 | - | - | - | Upgrade
|
Total Current Liabilities | 1.01 | 1.21 | 1.54 | 0.86 | 0.35 | 0.68 | Upgrade
|
Long-Term Debt | 0.14 | 0.14 | 0.36 | 0.38 | 0.7 | 0.38 | Upgrade
|
Total Liabilities | 1.15 | 1.35 | 1.9 | 1.25 | 1.05 | 1.06 | Upgrade
|
Common Stock | 25.33 | 25.06 | 24.03 | 23.03 | 14.14 | 11.89 | Upgrade
|
Additional Paid-In Capital | 3.69 | 3.8 | 3.82 | 2.46 | 2.16 | 1.81 | Upgrade
|
Retained Earnings | -25.28 | -23.28 | -22.6 | -17.04 | -13.97 | -10.66 | Upgrade
|
Shareholders' Equity | 3.75 | 5.58 | 5.24 | 8.46 | 2.32 | 3.03 | Upgrade
|
Total Liabilities & Equity | 4.89 | 6.94 | 7.13 | 9.7 | 3.37 | 4.09 | Upgrade
|
Total Debt | 0.52 | 0.76 | 0.76 | 0.75 | 0.9 | 0.96 | Upgrade
|
Net Cash (Debt) | 4.15 | 6.06 | 6.26 | 8.87 | 2.41 | 3.07 | Upgrade
|
Net Cash Growth | -2.15% | -3.18% | -29.47% | 267.99% | -21.41% | - | Upgrade
|
Net Cash Per Share | 0.08 | 0.12 | 0.13 | 0.20 | 0.06 | 0.12 | Upgrade
|
Filing Date Shares Outstanding | 51.64 | 51.64 | 49.68 | 49.21 | 40.49 | 36.33 | Upgrade
|
Total Common Shares Outstanding | 51.64 | 51.46 | 49.66 | 47.78 | 40.49 | 36.33 | Upgrade
|
Working Capital | 3.89 | 5.73 | 5.59 | 8.84 | 3.02 | 3.41 | Upgrade
|
Book Value Per Share | 0.07 | 0.11 | 0.11 | 0.18 | 0.06 | 0.08 | Upgrade
|
Tangible Book Value | 3.75 | 5.58 | 5.24 | 8.46 | 2.32 | 3.03 | Upgrade
|
Tangible Book Value Per Share | 0.07 | 0.11 | 0.11 | 0.18 | 0.06 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.